WMCC Achieves Reaccreditation with Distinction in Radiation Oncology
West Michigan Cancer Center Radiation & Surgical Specialties (WMCC) proudly announces it has earned a prestigious four-year reaccreditation by the American College of Radiation Oncology (ACRO), coupled with an outstanding Special Distinction in Stereotactic Radiotherapy. Mazen Mislmani, MD, division chief, leads WMCC’s exceptional radiation oncology program, which has now achieved a distinction shared by only two other practices nationwide.
The ACRO accreditation process is a hallmark of excellence in ensuring radiation oncology practices are held to the highest quality standards. It is a voluntary endeavor, subjecting our practice to scrutiny by professional peers who define the gold standard for quality. “Rigorous audits ensure compliance with these exacting standards,” said Dr. Mislmani. “In our pursuit of this recognition, WMCC underwent extensive peer reviews, including several months-long assessments of patient care, safety protocols, technological advancements, and comprehensive on-site evaluations, scrutinizing everything from staffing to quality assurance, safety protocols, and operational workflows.”
“Accreditation is critical to the mission at WMCC as it signifies achievement in the areas of quality and patient safety as well as recognition by peers in the field of radiation oncology,” said Bridget VandenBussche, CPHRM, WMCC executive director. “We know that a diagnosis of cancer is a life- changing experience for patients and their loved ones. We want our patients to know that the treatment they are receiving is being delivered at a high quality and safe organization. I could not be prouder of the entire team at WMCC.”
“The Special Distinction is a peer-crafted program designed to honor practices excelling in Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) treatments for specific disease sites including genitourinary, intracranial and central nervous system, liver, lung, pancreas and spine. “This recognition affirms the dedication of our entire team at WMCC to continually improve and embrace new technology to ensure the best outcomes for our patients,” said Renu Sharma, MS, WMCC director of medical physics.
The American College of Radiation Oncology steadfastly upholds the highest standards of care for radiation therapy patients and champions success in the field through education, responsible socioeconomic advocacy, and the integration of cutting-edge science and technology into clinical practice.
ABOUT WEST MICHIGAN CANCER CENTER RADIATION & SURGICAL SPECIALTIES
Founded in 1994 as a not-for-profit collaboration between Ascension Borgess and Bronson Healthcare, West Michigan Cancer Center Radiation & Surgical Specialties (WMCC) has been a beacon of hope for cancer patients. From its 55,000 square-foot facility at 200 North Park Street in downtown Kalamazoo, WMCC offers comprehensive, multidisciplinary, and integrative cancer treatment. Annually, WMCC welcomes around 2,000 new patients seeking its expert guidance and care.
An executive director, board of directors and senior medical staff comprise the leadership team. Service offerings include radiation oncology, gynecologic oncology, and surgical oncology. Licensed medical social workers and a registered dietitian offer assistance with basic needs, transportation, lodging, coping skills, nutrition counseling, resource navigation and more.
WMCC proudly participates in the Cancer Research Consortium of West Michigan (CRCWM), an affiliate of the National Cancer Institute Clinical Oncology Research Program (NCORP). The center holds accreditations from the American College of Radiation Oncology (ACRO), the Accreditation Commission for Health Care (ACHC), and the National Pancreas Foundation, reflecting its unwavering commitment to exceptional patient care and clinical excellence.